Intermediate-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor Is a Valid Alternative to High-Dose Cyclophosphamide for Mobilizing Peripheral Blood CD34+ Cells in Patients with Multiple Myeloma

Publisher： Karger

E-ISSN： 1421-9662|109|4|184-188

ISSN： 0001-5792

Source： Acta Haematologica, Vol.109, Iss.4, 2003-07, pp. : 184-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Timing (Preemptive versus Supportive) of Granulocyte Colony-Stimulating Factor Administration following High-Dose Cyclophosphamide

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 28-35

Karger

Access to resources Recommend Favorite

Cyclophosphamide plus granulocyte‐colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 31, Iss. 5, 2016-10 ,pp. : 423-428

John Wiley & Sons Inc

Access to resources Recommend Favorite

Kinetics of Granulocyte Colony-Stimulating Factor in the Human Milk of a Nursing Donor Receiving Treatment for Mobilization of the Peripheral Blood Stem Cells

By  

Acta Haematologica, Vol. 118, Iss. 3, 2007-10 ,pp. : 176-177

Karger

Access to resources Recommend Favorite

Biosimilar granulocyte–colony‐stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology‐oncology patients

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 246-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 282-288

Karger

Access to resources Recommend Favorite